AGER and diabetes mellitus: A recent study discovered that EUL alleviates diabetes‐induced renal injury by inhibiting the formation of advanced glycation end products (AGEs) and their cross‐linking with receptors of advanced glycation end products (RAGE) by activating the nuclear factor erythroid 2‐related factor 2 (Nrf2) signaling pathway, which reduces the oxidative stress response (Do et al., 2018).